These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 1008511

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
    Edvardsson U, Alexandersson M, Brockenhuus von Löwenhielm H, Nyström AC, Ljung B, Nilsson F, Dahllöf B.
    Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-18 protein level is upregulated in adipose tissue of obese mice.
    Membrez M, Ammon-Zufferey C, Philippe D, Aprikian O, Monnard I, Macé K, Darimont C.
    Obesity (Silver Spring); 2009 Feb; 17(2):393-5. PubMed ID: 19039317
    [Abstract] [Full Text] [Related]

  • 24. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
    Poyet C, Feldman JM.
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):355-76. PubMed ID: 7043679
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, Patel J, Ge H, Weiszmann J, Lu SC, Graham M, Busby J, Hecht R, Li YS, Li Y, Lindberg R, Véniant MM.
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [Abstract] [Full Text] [Related]

  • 31. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
    O'Harte FP, Franklin ZJ, Irwin N.
    Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice.
    Assimacopoulos-Jeannet F, Cantau B, van de Werve G, Jard S, Jeanrenaud B.
    Biochem J; 1983 Nov 15; 216(2):475-80. PubMed ID: 6318739
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Specificity of insulin action of fat cell of the Zucker genetically obese rat "fatty". [I] "Insulin binding capacity of fat cell membranes and the effects of proinsulin on insulin-receptor interation" (author's transl)].
    Ueda Y.
    Nihon Naibunpi Gakkai Zasshi; 1977 May 20; 53(5):669-78. PubMed ID: 913704
    [No Abstract] [Full Text] [Related]

  • 39. Insulin binding to isolated liver nuclei from obese and lean mice.
    Goidl JA.
    Biochemistry; 1979 Aug 21; 18(17):3674-9. PubMed ID: 476079
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.